AbCellera Biologics Inc (ABCL) Price Targets From Analysts
Use the tables below to see what analysts covering AbCellera Biologics Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 5 | $55 | $25 | $45.4 | $17.73 | 156.06% |
The Trend in the Analyst Price Target
ABCL's average price target has moved down $10.4 over the prior 27 weeks.
Over the past 35 weeks, ABCL's average upside potential has been 99.58%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-11 | 5 | 55 | 25 | 45.4 | 18.99 | 139.07% |
| 2021-09-04 | 5 | 55 | 25 | 45.4 | 18.74 | 142.26% |
| 2021-08-28 | 5 | 55 | 25 | 45.4 | 17.58 | 158.25% |
| 2021-08-14 | 5 | 55 | 25 | 45.8 | 17.89 | 156.01% |
| 2021-08-07 | 5 | 55 | 25 | 47.2 | 14.97 | 215.3% |
| 2021-08-05 | 5 | 55 | 25 | 47.2 | 15.61 | 202.37% |
| 2021-08-01 | 5 | 55 | 25 | 47.2 | 15.17 | 211.14% |
| 2021-07-24 | 5 | 55 | 25 | 47.2 | 15.79 | 198.92% |
| 2021-07-17 | 5 | 55 | 45 | 51.2 | 16.93 | 202.42% |
| 2021-07-10 | 5 | 55 | 45 | 51.2 | 19.37 | 164.33% |
| 2021-07-03 | 5 | 55 | 45 | 51.2 | 20.48 | 150% |
| 2021-06-26 | 5 | 55 | 45 | 51.2 | 20.74 | 146.87% |
| 2021-06-13 | 5 | 55 | 45 | 51.2 | 25.90 | 97.68% |
| 2021-06-05 | 5 | 55 | 45 | 51.2 | 25.97 | 97.15% |
| 2021-05-22 | 5 | 55 | 45 | 51.2 | 32.03 | 59.85% |
| 2021-05-15 | 5 | 55 | 45 | 51.2 | 31.75 | 61.26% |
| 2021-05-08 | 5 | 55 | 45 | 51.6 | 29.09 | 77.38% |
| 2021-04-25 | 5 | 55 | 45 | 52.2 | 29.33 | 77.97% |
| 2021-04-17 | 5 | 55 | 45 | 52.2 | 29.82 | 75.05% |
| 2021-04-10 | 5 | 55 | 45 | 52.4 | 28.35 | 84.83% |
| 2021-04-03 | 5 | 55 | 45 | 52.4 | 30.71 | 70.63% |
| 2021-03-20 | 5 | 61 | 52 | 55.8 | 31.20 | 78.85% |
| 2021-03-13 | 5 | 61 | 52 | 55.8 | 36.54 | 52.71% |
| 2021-03-06 | 5 | 61 | 52 | 55.8 | 28.61 | 95.04% |
| 2021-02-27 | 5 | 61 | 52 | 55.8 | 37.71 | 47.97% |
| 2021-02-20 | 5 | 61 | 52 | 55.8 | 44.07 | 26.62% |
| 2021-02-13 | 5 | 61 | 52 | 55.8 | 42.97 | 29.86% |
| 2021-02-06 | 5 | 61 | 45 | 54.4 | 46.55 | 16.86% |
| 2021-01-30 | 5 | 61 | 45 | 54.4 | 52.83 | 2.97% |
| 2021-01-23 | 5 | 59 | 45 | 51.4 | 50.50 | 1.78% |
| 2021-01-16 | 5 | 59 | 45 | 51.4 | 44.41 | 15.74% |
| 2021-01-09 | 5 | 59 | 45 | 51.4 | 39.72 | 29.41% |
ABCL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 2 | 3 | 0 | 0 | 0 | 5 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ABCL has a greater upside potential (average analyst target price relative to current price) than 88.26% of all US stocks.
- ABCL has a lower variance in analysts' estimates than 14.16% of all US stocks.
- AbCellera Biologics Inc's number of analysts covering the stock is higher than 6.41% of stocks in the large market cap category.
- The average analyst price target of ABCL is greater than 75.52% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, KNSA, VERU and FUSN are the three stocks most similar to AbCellera Biologics Inc regarding the price target and analyst recommendation information presented here.
Is ABCL a Buy, Hold or Sell? See the POWR Ratings now!